Injective (INJ) is a decentralized smart contract platform built to support decentralized finance (DeFi) applications, specializing in fast and low-cost transactions. Powered by Cosmos and Ethereum, Injective enables a highly interoperable and customizable blockchain solution with a focus on DeFi. Its unique Proof of Stake consensus mechanism provides security while supporting sustainable scalability. Injective’s decentralized order book, cross-chain capability, and composability make it a powerful tool for developers and users alike in the DeFi space. Known for its speed and efficiency, Injective appeals to users and institutions looking to access decentralized markets without high fees or intermediaries. With its open-source structure, Injective's platform allows for a range of DeFi applications, such as spot trading, derivatives, and synthetic assets. Users can buy, sell, and trade Injective on various exchanges, with live market data, historical trends, and analytics available on our Injective Markets page to help you stay informed on the latest trends and updates in the DeFi space.
Bitcoin fell under $77K after hot U.S. PPI data fueled Fed rate hike fears, driving $562M in crypto liquidations.
Nasdaq Ventures will invest $100 million in Kraken parent Payward as the firms expand their tokenized stock partnership.
Coinbase CEO Brian Armstrong says bitcoin has likely bottomed as stablecoins, tokenization and crypto growth gain steam.
Liquid's phased resumption follows a major exploit. Read about the Liquid team's actions post-hack and future security plans.
MAKE Group launches a cross-chain bridging protocol on Casper, bridging $32B+ in tokenized real-world assets across EVM chains.
